GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zota Health Care Ltd (NSE:ZOTA) » Definitions » Debt-to-EBITDA

Zota Health Care (NSE:ZOTA) Debt-to-EBITDA : 0.00 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Zota Health Care Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Zota Health Care's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Zota Health Care's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Zota Health Care's annualized EBITDA for the quarter that ended in Dec. 2023 was ₹139 Mil. Zota Health Care's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Zota Health Care's Debt-to-EBITDA or its related term are showing as below:

NSE:ZOTA' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.23   Med: 0.62   Max: 4.63
Current: 4.48

During the past 13 years, the highest Debt-to-EBITDA Ratio of Zota Health Care was 4.63. The lowest was 0.23. And the median was 0.62.

NSE:ZOTA's Debt-to-EBITDA is ranked worse than
77.45% of 275 companies
in the Biotechnology industry
Industry Median: 1.36 vs NSE:ZOTA: 4.48

Zota Health Care Debt-to-EBITDA Historical Data

The historical data trend for Zota Health Care's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zota Health Care Debt-to-EBITDA Chart

Zota Health Care Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.91 4.63

Zota Health Care Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 7.44 - 2.61 -

Competitive Comparison of Zota Health Care's Debt-to-EBITDA

For the Biotechnology subindustry, Zota Health Care's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zota Health Care's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zota Health Care's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Zota Health Care's Debt-to-EBITDA falls into.



Zota Health Care Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Zota Health Care's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(88.587 + 362.631) / 97.518
=4.63

Zota Health Care's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / 139.376
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Zota Health Care  (NSE:ZOTA) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Zota Health Care Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Zota Health Care's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Zota Health Care (NSE:ZOTA) Business Description

Traded in Other Exchanges
N/A
Address
2/896, Hira Modi Street, Zota House, Sagrampura, Surat, GJ, IND, 395002
Zota Health Care Ltd is engaged in manufacturing, trading and export of pharmaceutical products. The company caters to both domestic and international markets. It offers a vast range of pharmaceutical, nutraceutical, ayurvedic, and OTC products in India and overseas as well.

Zota Health Care (NSE:ZOTA) Headlines

No Headlines